A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Clinical trial NCT07292168 · RECRUITING

Trial details

NCT number: NCT07292168
Sponsor: Kidney Cancer Research Bureau
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma Metastatic Prostate Cancer Metastatic Non-small Cell Lung Cancer Metastatic Breast Cancer Metastatic Head & Neck Cancer

Start date: 2025-12-02
Primary completion: 2027-01-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.